Solventum Corporation
SOLVLast close · Oct 16, 202685.81−2.05 (−2.33%)
Market cap$14.6B
5 firms' latest targets, last 90 days: median $101.00 ($95.00–$113.00), 18% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-08-06 | Stifel | $100.00 | ▲ 11% | +17% |
| 2026-08-06 | UBS | $101.00 | ▲ 6% | +18% |
| 2026-08-06 | Mizuho Securities | $113.00 | ▲ 13% | +32% |
| 2026-08-06 | KeyBanc | $102.00 | ▲ 10% | +19% |
| 2026-08-06 | BTIG | $95.00 | ▲ 4% | +11% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $8.2B | +1% | $7.79 | +0% | est. $8.2B+0% | est. $7.47 | 5 |
| 2024reported | $8.3B | +1% | $2.76 | -65% | est. $8.2B+0% | est. $6.59 | 6 |
| 2025reported | $8.3B | +1% | $8.88 | +222% | est. $8.3B+1% | est. $6.03 | 8 |
| 2026 | $8.2B | -1% | $7.16 | +19% | $8.1B–$8.3B | $7.07–$7.49 | 10 |
| 2027 | $8.5B | +4% | $7.33 | +2% | $8.4B–$8.6B | $6.55–$7.71 | 10 |
| 2028 | $8.9B | +4% | $8.07 | +10% | $8.7B–$9.0B | $4.21–$10.67 | 11 |
| 2029 | $9.2B | +4% | $8.58 | +6% | $9.1B–$9.3B | $8.40–$8.67 | 5 |
| 2030 | $9.6B | +4% | $11.18 | +30% | $9.5B–$9.7B | $10.95–$11.29 | 5 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.